In this episode of The Story Behind the AP Story, we hear from Lauran Neergaard and Shelby Lum, who have been following the ...

Since the first human ... options in xenotransplantation could help us develop new potentially viable sources of organs. With a more holistic approach that embraces the full range of opportunities ...

A pig with a similar level of genetic modification served as the heart donor for the historical first pig-to-human clinical xenotransplantation performed ... The second trial, sponsored by United ...

Find out in our full research report, it’s free. Founded by a mother seeking treatment for her daughter's pulmonary arterial hypertension, United Therapeutics (NASDAQ:UTHR) develops and ...

Is now the time to buy United Therapeutics? Access our full analysis of the earnings results here, it’s free. Pioneering treatments for conditions that often had no previous therapeutic options ...

It is worth considering United Therapeutics (UTHR), which belongs to the Zacks Medical - Drugs industry. This drugmaker has an established record of topping earnings estimates, especially when ...

It doesn't matter your age or experience: taking full advantage of the stock market ... Silver Spring, MD-based United Therapeutics Corporation markets four medicines in the United States to ...

United Therapeutics Corporation (Nasdaq ... We have fun, we do good. We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC).

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands ...

BofA lowered the firm’s price target on United Therapeutics (UTHR ... position with detailed competitor analyses. Published first on TheFly – the ultimate source for real-time, market-moving ...